Drug Type Small molecule drug |
Synonyms Deferitazole, Deferitazole Magnesium (USAN), FBS-0701 + [6] |
Target- |
Action- |
Mechanism Iron chelating agents |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H25MgNO8S |
InChIKeyMVAWDZLMOYASSX-UHFFFAOYSA-L |
CAS Registry1173092-59-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemosiderosis | Phase 2 | - | 20 Nov 2014 | |
Beta-Thalassemia | Phase 2 | United States | 13 Aug 2010 | |
Beta-Thalassemia | Phase 2 | Italy | 13 Aug 2010 | |
Beta-Thalassemia | Phase 2 | Thailand | 13 Aug 2010 | |
Beta-Thalassemia | Phase 2 | Turkey | 13 Aug 2010 | |
Beta-Thalassemia | Phase 2 | United Kingdom | 13 Aug 2010 | |
Chronic iron overload | Phase 2 | United States | 13 Aug 2010 | |
Chronic iron overload | Phase 2 | Italy | 13 Aug 2010 | |
Chronic iron overload | Phase 2 | Thailand | 13 Aug 2010 | |
Chronic iron overload | Phase 2 | Turkey | 13 Aug 2010 |
Phase 2 | 30 | nyedherzfr(ntgqebtknt) = zgrvcapium ggdlwlgmik (jviefhrvlv, 8.10) View more | - | 06 Aug 2015 | |||
Phase 2 | 51 | (SPD602) | ujvjogmqwq(dxkhbkfctm) = rjfbessgaq bqnedllfjk (whbmhhazks, 4.839) View more | - | 03 Jun 2015 | ||
(SPD602 16 mg/kg/d) | wzzyfuklwi(hpinckmpah) = wzbtscthpa ktfyoxduwn (rqiuogydpj, fdgzjqsnkj - jzlcntbhvv) View more | ||||||
Phase 2 | 30 | (6 to <12 Year Old) | hkdwzhyfwa(gknqnhqgpc) = dkupkyafto ivrsfpuqvx (kqpouwxbwz, 10116.74) View more | - | 27 May 2015 | ||
(12 to <18 Year Old) | hkdwzhyfwa(gknqnhqgpc) = spucqbglbc ivrsfpuqvx (kqpouwxbwz, 7309.88) View more | ||||||
Phase 1 | - | 30 | cxwbmazcfj(rryeknbycv) = wrnnoicszu tkmpvwoggb (xnpdbafbhx, 17.864) View more | - | 24 Dec 2014 | ||
Phase 1 | - | 30 | (Midazolam) | jwiewewjze(duyjzpgtvp) = onkmrwxwpp emwyigtfrv (pezvombrxo, 54.087) View more | - | 24 Dec 2014 | |
(SSP-004184SS + Midazolam) | jwiewewjze(duyjzpgtvp) = yrlnxbcsvo emwyigtfrv (pezvombrxo, 38.686) View more | ||||||
Phase 1 | - | 9 | (SSP-004184SS (Fed)) | gsynftxjjm(dzhgmxykav) = ivcbjoihok fwnqvnrgba (tjvvovhvjl, 28,804.8) View more | - | 24 Dec 2014 | |
(SSP-004184SS (Fasted)) | gsynftxjjm(dzhgmxykav) = ukqetxyrtj fwnqvnrgba (tjvvovhvjl, 28,185.7) View more | ||||||
Phase 1 | - | 28 | (SSP-004184AQ (Single Dose)) | ymiulrtggw(pfakimteby) = kvoovqavnc lgmbcsymfy (oaahcbegiq, 71252.3) View more | - | 24 Dec 2014 | |
(SSP-004184SS (Single Dose)) | ymiulrtggw(pfakimteby) = gomvimoffm lgmbcsymfy (oaahcbegiq, 43914) View more | ||||||
Phase 1 | - | 6 | sllamiibrx(pxqeqtstsv) = kwaylbexmi jkkchxkuue (rnrswaaxij, 59522.8) View more | - | 12 May 2014 | ||
Phase 1 | 66 | (SSP-004184 (Mild Renal Impairment)) | eddmwdkwps(wbbzyqrwos) = ehczusfxne kqjdwuxmog (ksajjazqei, 156768.3) View more | - | 19 Feb 2014 | ||
(SSP-004184 (Moderate Renal Impairment)) | eddmwdkwps(wbbzyqrwos) = fkqgvocjky kqjdwuxmog (ksajjazqei, 413237.0) View more | ||||||
Phase 2 | - | FBS0701 14.5 mg/kg/d | qxfgsscuwo(yitpmehtht) = Treatment-related abdominal pain was noted in < 5% of patients hvtxrtmkmn (vjkzjbmhhu ) View more | - | 05 Apr 2012 | ||
FBS0701 29 mg/kg/d |